Upgrade to SI Premium - Free Trial

Silence Therapeutics to discuss Phase 2 divesiran trial results

August 9, 2026 5:00 PM
Silence Therapeutics plc (Nasdaq: SLN) announced it will host a conference call and ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

FDA